Delivery Order SPE2DP25D0002-SPE2DP26F1838
Award Date 1/22/26
Potential Completion Date 5/27/26
Potential Value $2.9M
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20814, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Valneva USA, Inc., a specialty vaccine manufacturer headquartered in Bethesda, Maryland and subsidiary of French-based Valneva SE, was awarded a delivery order valued at $8.25 million on October 23, 2025, for Japanese encephalitis vaccine (IXIARO) to support the Medical Supply Chain program within the Defense Department. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, represents performance at Valneva USA's Bethesda facility and carries no set-aside...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $4.41 million to Valneva USA, Inc. (doing business as Intercell USA Inc.) on January 7, 2026, for Japanese encephalitis vaccine (IXIARO), with final delivery expected by February 26, 2026. The contract carries firm fixed-price terms with no set-aside designation. Valneva USA, a Bethesda, Maryland-based subsidiary of French-based Valneva SE, is the sole prime contractor on this delivery order, which will be...
- This is a $16,016,000.00 firm fixed price delivery order awarded by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a subsidiary of the French specialty vaccine company Valneva SE. The contract is for the supply of the Japanese encephalitis vaccine IXIARO. This delivery order is part of a larger $48,025,600 indefinite delivery contract awarded to Valneva USA in September 2023, which supports the Department of Defense's medical...
- The Defense Logistics Agency Medical Supply Chain awarded a $5.15M firm fixed-price delivery order to Valneva USA, Inc. (doing business as Intercell USA Inc.) on January 22, 2026, for Japanese encephalitis vaccine (IXIARO), with an ultimate completion date of April 27, 2026. The award carries no set-aside designation and represents a child contract issued against one of Valneva USA's existing indefinite delivery vehicles with the Defense Logistics Agency. Valneva USA, a Bethesda,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 12, awarded a delivery order valued at $769,125.84 to Valneva USA, Inc. (doing business as Intercell USA Inc.) on October 1, 2024, for the supply of Japanese encephalitis virus vaccine (IXIARO). This firm fixed-price delivery order is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and carries an ultimate completion date of September 30, 2025. The contract includes no set-aside designation....
- This is a firm fixed-price delivery order contract awarded to Valneva USA, Inc., a subsidiary of the French vaccine company Valneva SE, by the Medical Supply Chain division of the U.S. Department of Defense. The $5,883,494.40 contract is for the provision of the Japanese encephalitis vaccine IXIARO, with a period of performance ending on July 31, 2025. Valneva USA, Inc. serves as the prime contractor and is responsible for vaccine production and delivery, primarily from its Potomac, Maryland...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Valneva USA, Inc. (a subsidiary of the French vaccine company Valneva SE) to supply the Japanese encephalitis vaccine IXIARO. The contract has a ceiling value of $48,000.00 and a completion date of December 31, 2025. It is part of a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $48,025,600, to support the Department of Defense's medical countermeasures...
- The Department of Health and Human Services Office of the Assistant Secretary for Administration awarded a $148,200.00 firm fixed price delivery order contract to Valneva USA, Inc. (doing business as Intercell USA Inc.) for the IXIARO vaccine. Valneva USA is a subsidiary of the French specialty vaccine company Valneva SE. The contract has no set-aside designation and was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The IXIARO vaccine is used to protect against...
- This is a firm fixed-price delivery order contract awarded to Valneva USA, Inc., a foreign-owned, for-profit organization based in Bethesda, Maryland. The contract, valued at $5,883,494.40, is for the delivery of the Japanese encephalitis vaccine IXIARO to support the Medical Supply Chain, a Defense agency. The contract does not have a set-aside designation and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Valneva USA, Inc. is the prime contractor responsible...
- This federal contract award, valued at $10,638,400.00, was issued by the Defense Logistics Agency Troop Support Medical to Valneva USA, Inc. (doing business as Intercell USA Inc.), a specialty vaccine company, for the supply of the Japanese encephalitis vaccine IXIARO. The contract is a firm fixed price delivery order with a period of performance through September 30, 2024. Valneva USA, a subsidiary of the France-based Valneva SE, is the prime contractor and holds several other significant...